Scarica l'app Stockscreener
4.0718
4.47%
-0.1782
Glucotrack Inc Borsa (GCTK) Ultime notizie
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia - marketscreener.com
Form 8K GlucoTrack Inc For: 19 August By Investing.com - Investing.com Nigeria
Glucotrack shareholders approve director elections, reverse split, and warrant inducement - Investing.com
Glucotrack Shareholders Approve Up to 1-for-30 Reverse Stock Split - Minichart
Glucotrack (NASDAQ: GCTK) investors back reverse split, warrant deal - Stock Titan
GlucoTrack Stock Short Interest Rises to 33.15% - Quiver Quantitative
GlucoTrack, Inc. (GCTK) Latest Stock News & Headlines - Yahoo Finance
Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances - Yahoo Finance
Glucotrack regains Nasdaq compliance on equity requirement By Investing.com - Investing.com South Africa
Glucotrack regains Nasdaq compliance on equity requirement - Investing.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Business Wire
Glucotrack Company Profile & Introduction - Moomoo
Glucotrack Inc. (GCTK) narrows loss, warns on going concern and closes Lokahi deal - Stock Titan
GlucoTrack, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GlucoTrack Amends Equity Financing and Issues Commitment Shares - TipRanks
GlucoTrack Inc (GCTK) Stock News Today - tradingkey.com
GlucoTrack Secures New Financing to Support Growth - The Globe and Mail
Glucotrack Raises $5.5M as It Settles Into Its New Identity as an AI-Driven Biopharma Platform - biobuzz.io
E.F. Hutton Advises on $5.5 Million Financing for Glucotrack Subsidiary Lōkahi Therapeutics - citybiz
E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack - The Manila Times
Glucotrack Secures $5.5 Million Financing With Premium Equity and Institutional Investment to Boost Growth - Minichart
Glucotrack Raises $5.5 Million Through Bridge Follow-On and Interim PIPE, Adds Registration Rights - TradingView
GlucoTrack, Inc. announced that it expects to receive $5.5 million in funding - marketscreener.com
Glucotrack Secures $5.5 Million Financing to Support Growth Strategy and Product Development - citybiz
Glucotrack Announces $5.5 Million Financing - marketscreener.com
Lōkahi Therapeutics Ai2 Futures Lab Changes How Biopharma Builds a Pipeline - 富途牛牛
Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline - marketscreener.com
GlucoTrack (GCTK) Shares Crash 40% to $0.47 as Critical Support Level ApproachesGap Up Stocks - vinanet.vn
GlucoTrack (GCTK) Stock Surges Over 70% After Hours: Why is it Moving? - webull.com
GlucoTrack surges as traders revisit Lōkahi merger and new financing package | GCTK Stock News - Quiver Quantitative
GlucoTrack, Inc. (NASDAQ:GCTK) surges 95% after LT-100 news, market eyes dilution impact - TechStock²
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Glucotrack (NASDAQ: GCTK) revises $900,000 debt-for-stock deal - Stock Titan
Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration - Yahoo Finance
GlucoTrack Restructures Debt Through Equity-Linked Note Exchange - theglobeandmail.com
GlucoTrack Creates $900,000 Partitioned Note, Enables Exchanges Into Stock at Market-Based Price - TradingView
Glucotrack (NASDAQ: GCTK) creates $900,000 exchangeable note for stock - Stock Titan
GlucoTrack Inc (GCTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GlucoTrack Inc (GCTK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GlucoTrack Inc (GCTK) Income Statement - TradingKey
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
GlucoTrack Inc (GCTK) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
GlucoTrack Inc (GCTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GlucoTrack Inc (NASDAQ: GCTK) Stock Price, News & Analysis - Kalkine
GCTK|GlucoTrack Inc|Price:0.297|Chg%:+0.006 - TradingKey
GCTK|GlucoTrack Inc|Price:0.294|Chg%:+0.003 - TradingKey
GlucoTrack Inc (GCTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GCTK|GlucoTrack Inc|Price:0.291|Chg%:-0.021 - TradingKey
GCTK|GlucoTrack Inc|Price:0.340|Chg%:-0.002 - TradingKey
GlucoTrack Inc (GCTK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
GlucoTrack (GCTK) stock rallies 16% after hours: Here's what is going on - MSN
GlucoTrack Inc. (GCTK) Faces Sharp Decline: $0.42 Level Critical for StabilitySector ETF Flow - Vinanet
GlucoTrack Inc. (GCTK) Holds Near Key Support After Modest DeclineDemand Zone - dars.gov.et
GlucoTrack Inc. (GCTK) Slips Slightly Amid Consolidation Near Key SupportVolume Spike Alerts - dars.gov.et
0.96%
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):